Matthew Emmens's Net Worth

$97.1 Million

Estimate Recalculated Nov 11, 2024 07:43AM EST

Who is Matthew Emmens

Matthew Emmens has an estimated net worth of $97.1 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, VERTEX PHARMACEUTICALS INC / MA, and INCYTE CORP.

SEC CIK

Matthew Emmens's CIK is 0001298332

Past Insider Trading and Trends

2017 was Matthew Emmens's most active year for acquiring shares with 5 total transactions. Matthew Emmens's most active month to acquire stocks was the month of January. 2011 was Matthew Emmens's most active year for disposing of shares, totalling 4 transactions. Matthew Emmens's most active month to dispose stocks was the month of January. 2021 saw Matthew Emmens paying a total of $226,249.98 for 3,628.383 shares, this is the most they've acquired in one year. In 2011 Matthew Emmens cashed out on 65,735 shares for a total of $2,656,131.85, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BRISTOL MYERS SQUIBB CO

Investor
Updated Apr 02, 2021
Form 4
2.17%
574.21
$63.13
$36.25K
Apr 02, 2021
27.00K
Grant
Mar 31
Form 4
13.07%
3.05K
$62.21
$190.00K
Feb 03, 2021
26.42K
Grant
Feb 01
Form 4
2.59%
584.39
$62.03
$36.25K
Jan 05, 2021
23.19K
Grant
Dec 31
Form 4
2.75%
601.26
$60.29
$36.25K
Oct 02, 2020
22.43K
Grant
Sep 30
Form 4
2.93%
616.50
$58.80
$36.25K
Jul 02, 2020
21.67K
Grant
Jun 30
Form 4
3.21%
650.34
$55.74
$36.25K
Apr 02, 2020
20.90K
Grant
Mar 31
Form 4
17.52%
3.02K
$62.95
$190.00K
Feb 04, 2020
20.24K
Grant
Feb 01
Form 4
3.41%
564.73
$64.19
$36.25K
Jan 03, 2020
17.11K
Grant
Dec 31
Form 4
4.55%
714.85
$50.71
$36.25K
Oct 02, 2019
16.42K
Grant
Sep 30
Form 4
5.19%
767.54
$45.35
$34.81K
Jul 02, 2019
15.57K
Grant
Jun 30
Form 4
4.87%
681.20
$47.71
$32.50K
Apr 02, 2019
14.67K
Grant
Mar 31
Form 4
36.07%
3.71K
$49.89
$185.00K
Feb 05, 2019
13.99K
Grant
Feb 01
Form 4
6.62%
625.24
$51.98
$32.50K
Jan 03, 2019
10.06K
Grant
Dec 31
Form 4
5.87%
523.52
$62.08
$32.50K
Oct 02, 2018
9.44K
Grant
Sep 30
Form 4
7.05%
587.28
$55.34
$32.50K
Jul 03, 2018
8.92K
Grant
Jun 30
Form 4
6.63%
513.83
$63.25
$32.50K
Apr 03, 2018
8.27K
Grant
Mar 31
Form 4
61.30%
2.95K
$62.80
$185.00K
Feb 05, 2018
7.75K
Grant
Feb 01
Form 4
12.49%
530.35
$61.28
$32.50K
Jan 03, 2018
4.78K
Grant
Dec 31
Form 4
13.75%
509.88
$63.74
$32.50K
Oct 03, 2017
4.22K
Grant
Sep 30
Form 4
17.08%
537.42
$55.72
$29.95K
Jul 05, 2017
3.68K
Grant
Jun 30
Form 4
6.81%
199.22
$54.38
$10.83K
Apr 04, 2017
3.12K
Grant
Mar 31
Form 4
2.92K
$54.78
$160.22K
Feb 23, 2017
2.92K
Grant
Feb 21
Form 3
Feb 23, 2017
260.00
Showing 23 results

VERTEX PHARMACEUTICALS INC / MA

Executive Chairman
Updated Nov 20, 2012
Form 4
-5.12%
-10.85K
$41.76
-$453.10K
Nov 20, 2012
200.87K
Sale
Nov 16
Form 4
20.00K
Jun 01, 2012
20.00K
Grant
Jun 01
Form 4
-20.93%
-56.00K
$37.78
-$2.12M
Feb 07, 2012
211.60K
Sale
ScheduledFeb 06
Form 4
128.49%
283.20K
$0.01
$472.01
Feb 06, 2012
503.60K
Grant
Feb 02
Form 4
118.00K
Jul 14, 2011
118.00K
Grant
Jul 13
Form 4
-4.23%
-9.73K
$55.51
-$540.39K
May 26, 2011
220.40K
Sale
May 25
Form 4
155.43%
283.20K
$0.01
$472.01
Feb 07, 2011
465.41K
Grant
Feb 03
Form 4
118.00K
Jul 16, 2010
118.00K
Grant
Jul 14
Form 4
297.18%
401.20K
$0.01
$472.01
Feb 08, 2010
536.21K
Grant
Feb 04
Form 4
683.13K
$0.01
$1.34K
Feb 06, 2009
683.13K
Grant
Feb 05
Form 4
20.00K
Jun 02, 2008
20.00K
Grant
Jun 01
Form 4
20.00K
Jun 04, 2007
20.00K
Grant
Jun 01
Form 4
66.67%
20.00K
Jun 02, 2006
50.00K
Grant
Jun 01
Form 4
50.00%
10.00K
Jun 03, 2005
30.00K
Grant
Jun 01
Form 3
Jul 26, 2004
Showing 15 results

INCYTE CORP

Investor
Updated May 22, 2008
Form 4
20.00K
May 22, 2008
20.00K
Grant
May 22
Form 4
20.00K
May 22, 2007
20.00K
Grant
May 22
Form 3
May 23, 2006
Form 4
35.00K
May 23, 2006
35.00K
Grant
May 23
Showing 4 results